Candriam SCA’s DBV Technologies DBVT Stock Holding History

Candriam SCA’s Portfolio DBVT Stock Details DBVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-5,000	Closed	-$965K	–	818
2018 Q2	$965K	Hold	5,000	–	–	0.02%	621
2018 Q1	$1.15M	Hold	5,000	–	–	0.02%	573
2017 Q4	$1.23M	Buy	+5,000	New	+$1.45M	0.02%	555

Other funds holding DBVT

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Candriam SCA's DBVT Position: Q3 2018 in Review

Candriam SCA sold out of DBV Technologies (DBVT) in Q3 2018, closing a stake of 5,000 shares — an estimated $965K sold.

Candriam SCA first reported a position in DBVT in Q4 2017 and held it in 3 quarters. The position peaked at $1.23M in Q4 2017. 61 funds tracked by Wall St. Rank hold DBVT as of Q3 2018.

Candriam SCA reported no remaining DBV Technologies position as of Q3 2018 after selling out during the quarter.
Candriam SCA sold 5,000 DBV Technologies shares in Q3 2018, an estimated $965K.
Candriam SCA first reported a position in DBV Technologies in Q4 2017 and held it in 3 quarters.
Candriam SCA's DBV Technologies position peaked at $1.23M in Q4 2017.
61 funds tracked by Wall St. Rank held DBV Technologies as of Q3 2018.

Based on Candriam SCA's 13F filing for Q3 2018, filed 7 Nov 2018.